연구성과로 돌아가기
2023 연구성과별 연구자 정보 (349 / 2675)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Cardiovascular risk of Janus kinase inhibitors compared with biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis without underlying cardiovascular diseases: a nationwide cohort study | Kwon, Jin-Won | Kwon, JW | 5 | 교신저자 | Kyungpook Natl Univ, Res Inst Pharmaceut Sci, Daegu, South Korea | jwkwon@knu.ac.kr; | ||||
| Cardiovascular Toxicity after Carfilzomib, Lenalidomide, and Dexamethasone Combination Chemotherapy in the Real-World 364 Asian Multiple Myeloma Patients on Behalf of the Korean Multiple Myeloma Working Party (KMM2201 study) | Lee, Ji Hyun | Lee, JH | 1 | Dong A Univ, Coll Med, Busan, South Korea | ||||||
| Cardiovascular Toxicity after Carfilzomib, Lenalidomide, and Dexamethasone Combination Chemotherapy in the Real-World 364 Asian Multiple Myeloma Patients on Behalf of the Korean Multiple Myeloma Working Party (KMM2201 study) | Min, Chang-Ki | Min, CK | 2 | Catholic Univ Korea, Seoul St Marys Hosp, Catholic Hematol Hosp, Coll Med,Dept Hematol, Seoul, South Korea | ||||||
| Cardiovascular Toxicity after Carfilzomib, Lenalidomide, and Dexamethasone Combination Chemotherapy in the Real-World 364 Asian Multiple Myeloma Patients on Behalf of the Korean Multiple Myeloma Working Party (KMM2201 study) | Jo, Jae-Cheol | Jo, JC | 3 | Ulsan Univ Hosp, Ulsan, South Korea | CAE-9453-2022 | Jo, Jae-Cheol | ||||
| Cardiovascular Toxicity after Carfilzomib, Lenalidomide, and Dexamethasone Combination Chemotherapy in the Real-World 364 Asian Multiple Myeloma Patients on Behalf of the Korean Multiple Myeloma Working Party (KMM2201 study) | Lee, Yoo Jin | Lee, YJ | 4 | Univ Ulsan, Ulsan Univ Hosp, Coll Med, Ulsan, South Korea | ||||||
| Cardiovascular Toxicity after Carfilzomib, Lenalidomide, and Dexamethasone Combination Chemotherapy in the Real-World 364 Asian Multiple Myeloma Patients on Behalf of the Korean Multiple Myeloma Working Party (KMM2201 study) | Kim, Jin Seok | Kim, JS | 5 | Yonsei Univ, Severance Hosp, Coll Med, Dept Internal Med,Div Hematol, Seoul, South Korea | I-6927-2019 | KIM, JIN | ||||
| Cardiovascular Toxicity after Carfilzomib, Lenalidomide, and Dexamethasone Combination Chemotherapy in the Real-World 364 Asian Multiple Myeloma Patients on Behalf of the Korean Multiple Myeloma Working Party (KMM2201 study) | Uhm, Hyun-Seok | Uhm, HS | 6 | Natl Canc Ctr, Goyang, South Korea | ||||||
| Cardiovascular Toxicity after Carfilzomib, Lenalidomide, and Dexamethasone Combination Chemotherapy in the Real-World 364 Asian Multiple Myeloma Patients on Behalf of the Korean Multiple Myeloma Working Party (KMM2201 study) | Jung, Jong Heon | Jung, JH | 7 | Natl Canc Ctr, Goyang, South Korea | ||||||
| Cardiovascular Toxicity after Carfilzomib, Lenalidomide, and Dexamethasone Combination Chemotherapy in the Real-World 364 Asian Multiple Myeloma Patients on Behalf of the Korean Multiple Myeloma Working Party (KMM2201 study) | Moon, Joon Ho | Moon, JH | 8 | Kyungpook Natl Univ Hosp, Daegu, South Korea | ||||||
| Cardiovascular Toxicity after Carfilzomib, Lenalidomide, and Dexamethasone Combination Chemotherapy in the Real-World 364 Asian Multiple Myeloma Patients on Behalf of the Korean Multiple Myeloma Working Party (KMM2201 study) | Cho, Hee Jeong | Cho, HJ | 9 | Kyungpook Natl Univ Hosp, Daegu, South Korea | ||||||
| Cardiovascular Toxicity after Carfilzomib, Lenalidomide, and Dexamethasone Combination Chemotherapy in the Real-World 364 Asian Multiple Myeloma Patients on Behalf of the Korean Multiple Myeloma Working Party (KMM2201 study) | Lee, Myung-won | Lee, MW | 10 | Chungnam Natl Univ Hosp, Daejeon, South Korea | ||||||
| Cardiovascular Toxicity after Carfilzomib, Lenalidomide, and Dexamethasone Combination Chemotherapy in the Real-World 364 Asian Multiple Myeloma Patients on Behalf of the Korean Multiple Myeloma Working Party (KMM2201 study) | Yoon, Sung-Soo | Yoon, SS | 11 | Seoul Natl Univ Hosp, Dept Hematooncol, Seoul, South Korea | ||||||
| Cardiovascular Toxicity after Carfilzomib, Lenalidomide, and Dexamethasone Combination Chemotherapy in the Real-World 364 Asian Multiple Myeloma Patients on Behalf of the Korean Multiple Myeloma Working Party (KMM2201 study) | Byun, Ja Min | Byun, JM | 12 | Seoul Natl Univ, Seoul, South Korea | ||||||
| Cardiovascular Toxicity after Carfilzomib, Lenalidomide, and Dexamethasone Combination Chemotherapy in the Real-World 364 Asian Multiple Myeloma Patients on Behalf of the Korean Multiple Myeloma Working Party (KMM2201 study) | Lee, Jae Hoon | Lee, JH | 13 | Gachon Univ, Gil Med Ctr, Incheon, South Korea | ||||||
| Cardiovascular Toxicity after Carfilzomib, Lenalidomide, and Dexamethasone Combination Chemotherapy in the Real-World 364 Asian Multiple Myeloma Patients on Behalf of the Korean Multiple Myeloma Working Party (KMM2201 study) | Lee, Je-Jung | Lee, JJ | 14 | Chonnam Natl Univ, Hwasun Hosp, Dept Hematol Oncol, Hwasun, South Korea |
페이지 이동: